News
|
January 16, 2025

FDA’s Red Dye No. 3 Ban: A Step Toward Cleaner and Safer Food Standards

Written By
Dr. Jessica Christie ND, CNS
Medically Reviewed by
Updated On
January 16, 2025

The U.S. Food and Drug Administration (FDA) has officially revoked the authorization for Red Dye No. 3 (erythrosine) in foods and ingested drugs, marking a pivotal moment in food safety regulation. 

This decision, announced in January 2025, is a significant step in addressing long-standing health concerns associated with the synthetic dye, which has been commonly used in the U.S. food supply for decades.

What Is Red Dye No. 3?

Red Dye No. 3 is a synthetic food coloring derived from petroleum and commonly used to create vibrant red hues in various food products. It has been a cost-effective and visually appealing option for manufacturers, appearing in candies, snack foods, baked goods, and certain medications. 

Despite its widespread use, the dye has been under scrutiny for years due to potential health risks, prompting consumer advocacy groups and researchers to push for stricter regulations.

The FDA’s Decision to Ban Red Dye No. 3

The FDA’s decision to revoke the use of Red Dye No. 3 in foods and ingested drugs follows decades of scientific research and public advocacy. Central to the ban is the Delaney Clause in the Federal Food, Drug, and Cosmetic Act, which prohibits the approval of any additive shown to cause cancer in humans or animals.

Animal studies conducted in the 1980s revealed that high doses of Red Dye No. 3 caused thyroid tumors in male rats. While these doses exceeded typical human exposure levels, the findings raised significant concerns about the dye's safety. Over time, growing evidence has supported the need for stricter regulations, culminating in this landmark FDA decision.

Manufacturers have until January 15, 2027, to comply with the ban for food products and until January 18, 2028, for ingested drugs. During this transition period, companies will need to reformulate products containing Red Dye No. 3 or remove them from the market altogether.

Global and State-Level Context

The FDA’s action brings the United States more in line with international food safety standards. Red Dye No. 3 has long been banned in many countries, including those in the European Union and Norway, where precautionary principles guide regulatory decisions.

At the state level, California’s 2023 Food Safety Act served as a precursor to this federal ban. The state law prohibits the use of Red Dye No. 3 and several other additives starting in 2027, reflecting the influence of state-level actions on national policy.

Health Risks Associated with Red Dye No. 3

The potential health risks linked to Red Dye No. 3 have been the subject of extensive research and debate. Key concerns include:

Cancer Risks

Animal studies have demonstrated that high doses of Red Dye No. 3 can induce thyroid tumors in male rats. While the doses tested in these studies are far higher than typical human exposure, the findings have fueled calls for a cautious approach. The Delaney Clause requires the FDA to prioritize public safety by banning additives with any evidence of carcinogenic potential.

Behavioral Impacts

Some studies have explored the possible effects of synthetic food dyes, including Red Dye No. 3, on behavior and neurodevelopment in children. Research published in the late 2000s suggested correlations between artificial dyes and hyperactivity in sensitive populations, prompting regulatory changes in other countries. For example, the European Union requires warning labels on foods containing synthetic dyes, including erythrosine.

Allergic Reactions

Although rare, some individuals may experience sensitivities to Red Dye No. 3, manifesting as skin irritation, headaches, or respiratory symptoms. These reactions underscore the importance of increased awareness and regulation for vulnerable populations.

Implications for the Food Industry

The FDA’s decision will have far-reaching effects on the food and pharmaceutical industries. Manufacturers will need to navigate several challenges as they adapt to the ban:

Reformulation Costs

Replacing Red Dye No. 3 with natural alternatives, such as beet juice or paprika extract, may increase production costs. Natural dyes can also affect the taste, texture, and shelf life of products, requiring additional research and development investments.

Regulatory Compliance

Companies must ensure compliance with the new regulations within the established timelines. Noncompliance could result in penalties or legal action, adding urgency to reformulation efforts.

Consumer Perception

The ban highlights a broader consumer shift toward transparency and clean-label products. Companies that proactively eliminate artificial dyes may gain a competitive advantage by appealing to health-conscious buyers.

Consumer Advocacy and Awareness

The FDA’s decision reflects decades of advocacy by groups like the Center for Science in the Public Interest (CSPI), which has long called for stricter regulations on synthetic dyes. Public demand for safer, minimally processed foods has driven significant changes in the food industry, influencing both state and federal policies.

Consumers can take proactive steps to reduce their exposure to synthetic dyes by:

  • Checking labels for “no artificial colors” or plant-based alternatives.
  • Choosing clean-label brands that prioritize transparency.
  • Supporting advocacy efforts to encourage safer ingredient sourcing.

A Step Toward Greater Food Safety

The FDA’s decision to ban Red Dye No. 3 underscores a broader shift toward prioritizing public health and safety in food regulation. This move reflects growing recognition of the potential risks associated with synthetic additives and aligns with international standards for precautionary measures.

As the food industry adapts to these changes, consumers can expect to see an increased focus on natural and transparent ingredient sourcing. The ban is not just a regulatory milestone but also a reflection of evolving consumer values and scientific understanding of food safety.

For Further Information

For more details on the FDA’s decision and its implications, visit the FDA’s official announcement here. Additional insights can be found in Newsweek’s coverage of the ban here.

This ban represents a significant step forward in ensuring the safety and transparency of the U.S. food supply, setting the stage for continued progress in food additive regulation.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Aitken, P., & Mesa, J. (2025, January 15). The FDA just banned red dye no. 3 from food, drinks—here are the potential side effects. Newsweek. https://www.newsweek.com/fda-bans-red-food-dye-side-effects-risks-list-2015727

California Legislative Information. (2023, October 9). Bill text - AB-418 the California food safety act. Leginfo.legislature.ca.gov. https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240AB418

Center for Food Safety and Applied Nutrition. (2023). FD&C red no. 3. FDA. https://www.fda.gov/industry/color-additives/fdc-red-no-3

Center for Science in the Public Interest. (n.d.). Center for science in the public interest. Center for Science in the Public Interest. https://www.cspinet.org

European Food Safety Authority. (2009). Food colours. European Food Safety Authority. https://www.efsa.europa.eu/en/topics/topic/food-colours

Hiasa, Y., Ohshima, M., Kitahori, Y., Konishi, N., Shimoyama, T., Sakaguchi, Y., Hashimoto, H., Minami, S., & Kato, Y. (1988). The promoting effects of food dyes, erythrosine (red 3) and rose bengal B (red 105), on thyroid tumors in partially thyroidectomized n-bis(2-hydroxypropyl)- nitrosamine-treated rats. Japanese Journal of Cancer Research, 79(3), 314–319. https://doi.org/10.1111/j.1349-7006.1988.tb01593.x

McCann, D., Barrett, A., Cooper, A., Crumpler, D., Dalen, L., Grimshaw, K., Kitchin, E., Lok, K., Porteous, L., Prince, E., Sonuga-Barke, E., Warner, J. O., & Stevenson, J. (2007). Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: A randomised, double-blinded, placebo-controlled trial. The Lancet, 370(9598), 1560–1567. https://doi.org/10.1016/s0140-6736(07)61306-3

U.S. Food & Drug Administration. (2019). Part III: Drugs and foods under the 1938 act and its amendments. FDA. https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/part-iii-drugs-and-foods-under-1938-act-and-its-amendments

U.S. Food & Drug Administration. (2025). Revoking authorization for the use of red no. 3 in food/ingested drugs. U.S. Food and Drug Administration. https://www.fda.gov/food/hfp-constituent-updates/fda-revoke-authorization-use-red-no-3-food-and-ingested-drugs

Weisbrod, D. B., Caruana, D. L., Li, D., Wan, L., & Szema, A. M. (2023). A case report of allergic hypersensitivity to color additives in Slurpee® beverages. Yale Journal of Biology and Medicine, 96(1), 79–82. https://doi.org/10.59249/kgft1011

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on News
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.